FI63404C - Foerfarande foer framstaellning av antianoxiska 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de) (1,5)naftyridiner - Google Patents

Foerfarande foer framstaellning av antianoxiska 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de) (1,5)naftyridiner Download PDF

Info

Publication number
FI63404C
FI63404C FI771159A FI771159A FI63404C FI 63404 C FI63404 C FI 63404C FI 771159 A FI771159 A FI 771159A FI 771159 A FI771159 A FI 771159A FI 63404 C FI63404 C FI 63404C
Authority
FI
Finland
Prior art keywords
formula
hooc
cooh
indolo
hexahydro
Prior art date
Application number
FI771159A
Other languages
English (en)
Finnish (fi)
Other versions
FI771159A (cs
FI63404B (fi
Inventor
Gabor Istvan Koletar
Henry Najer
Jean-Pierre Gaston Lefevre
Regis Dupont
Don Pierre Rene Luc Giudicelli
Claude Constant Henri Morel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7610773A external-priority patent/FR2358146A1/fr
Priority claimed from FR7616445A external-priority patent/FR2353550A2/fr
Priority claimed from FR7632319A external-priority patent/FR2368955A2/fr
Priority claimed from FR7639035A external-priority patent/FR2374905A2/fr
Priority claimed from FR7707249A external-priority patent/FR2383182A2/fr
Priority claimed from FR7707248A external-priority patent/FR2383181A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI771159A publication Critical patent/FI771159A/fi
Priority to FI803790A priority Critical patent/FI803790L/fi
Application granted granted Critical
Publication of FI63404B publication Critical patent/FI63404B/fi
Publication of FI63404C publication Critical patent/FI63404C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI771159A 1976-04-13 1977-04-13 Foerfarande foer framstaellning av antianoxiska 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de) (1,5)naftyridiner FI63404C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI803790A FI803790L (fi) 1976-04-13 1980-12-05 Foerfarande foer framstaellning av antianoxiska 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo/3,2,1-de/ /1,5/ naftyridiner

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
FR7610773 1976-04-13
FR7610773A FR2358146A1 (fr) 1976-04-13 1976-04-13 Derives de la tetrahydro-1,2,3,3a indolo(3,2,1-de) (1,5)naphtyridine
FR7616445 1976-06-01
FR7616445A FR2353550A2 (fr) 1976-06-01 1976-06-01 Procede de preparation de derives de naphtyridine
FR7632319 1976-10-27
FR7632319A FR2368955A2 (fr) 1976-10-27 1976-10-27 Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine
FR7639035A FR2374905A2 (fr) 1976-12-24 1976-12-24 Derives de naphtyridine
FR7639035 1976-12-24
FR7707249A FR2383182A2 (fr) 1977-03-11 1977-03-11 Nouveaux derives de naphtyridine
FR7707249 1977-03-11
FR7707248 1977-03-11
FR7707248A FR2383181A2 (fr) 1977-03-11 1977-03-11 Derives de naphtyridine

Publications (3)

Publication Number Publication Date
FI771159A FI771159A (cs) 1977-10-14
FI63404B FI63404B (fi) 1983-02-28
FI63404C true FI63404C (fi) 1983-06-10

Family

ID=27546337

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771159A FI63404C (fi) 1976-04-13 1977-04-13 Foerfarande foer framstaellning av antianoxiska 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de) (1,5)naftyridiner

Country Status (24)

Country Link
US (1) US4190657A (cs)
JP (1) JPS5823877B2 (cs)
AR (1) AR214519A1 (cs)
AU (1) AU506031B2 (cs)
CA (1) CA1072960A (cs)
CH (1) CH622795A5 (cs)
DD (1) DD129791A5 (cs)
DE (1) DE2716190A1 (cs)
DK (1) DK143703C (cs)
FI (1) FI63404C (cs)
GB (1) GB1543283A (cs)
GR (1) GR63658B (cs)
IE (1) IE44989B1 (cs)
IL (1) IL51853A (cs)
LU (1) LU77100A1 (cs)
MT (1) MTP811B (cs)
MX (1) MX5340E (cs)
NO (1) NO146777C (cs)
NZ (1) NZ183846A (cs)
PL (1) PL197373A1 (cs)
PT (1) PT66428B (cs)
SE (2) SE432932B (cs)
SU (1) SU655314A3 (cs)
YU (1) YU94877A (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5337696A (en) * 1976-08-26 1978-04-06 Omnium Chimique Sa Hexahydrocantinonee6 derivative
US4228168A (en) * 1978-11-22 1980-10-14 Tanabe Seiyaku Co., Ltd. Azepino [1,2,3-lm]-β-carboline compounds and pharmaceutical composition thereof
US4367230A (en) * 1980-01-04 1983-01-04 Tanabe Seiyaku Co., Ltd. Novel triazafluoranthene compound and processes for preparing the same
FR2494693A1 (fr) * 1980-11-21 1982-05-28 Synthelabo Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique
FR2517679A1 (fr) * 1981-12-03 1983-06-10 Synthelabo Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique
LU84664A1 (fr) * 1983-02-25 1984-11-08 Onmichem S A Alkyl-4-indolonaphtyridines et leur application therapeutique
EP0347980A1 (en) * 1988-06-20 1989-12-27 Duphar International Research B.V 8,9-Annelated beta-carbolines and 8,9-anelated-3,4-dihydro-beta-carbolines
CN103193776A (zh) * 2013-04-16 2013-07-10 苏州维泰生物技术有限公司 一种具有抗肿瘤疗效的新型萘啶衍生物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299078A (en) * 1962-10-01 1967-01-17 Smith Kline French Lab Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
US3555018A (en) * 1968-12-03 1971-01-12 Ayerst Mckenna & Harrison Thiazinopyridoindolone derivatives

Also Published As

Publication number Publication date
NO146777C (no) 1982-12-08
SE8201181L (sv) 1982-05-25
SE432932B (sv) 1984-04-30
MTP811B (en) 1978-02-20
AU506031B2 (en) 1979-12-13
GB1543283A (en) 1979-04-04
YU94877A (en) 1983-01-21
DK143703B (da) 1981-09-28
CH622795A5 (cs) 1981-04-30
DD129791A5 (de) 1978-02-08
PT66428B (fr) 1978-09-20
PL197373A1 (pl) 1978-02-13
SU655314A3 (ru) 1979-03-30
NO771263L (no) 1977-10-14
FI771159A (cs) 1977-10-14
DE2716190A1 (de) 1977-10-27
SE7704172L (sv) 1977-10-14
IL51853A0 (en) 1977-06-30
CA1072960A (en) 1980-03-04
AU2418977A (en) 1978-10-19
JPS52125198A (en) 1977-10-20
LU77100A1 (cs) 1979-01-18
US4190657A (en) 1980-02-26
DK161377A (da) 1977-10-14
IE44989B1 (en) 1982-06-02
IL51853A (en) 1979-11-30
FI63404B (fi) 1983-02-28
NO146777B (no) 1982-08-30
DK143703C (da) 1982-04-13
JPS5823877B2 (ja) 1983-05-18
PT66428A (fr) 1977-05-01
GR63658B (en) 1979-11-28
NZ183846A (en) 1980-09-12
AR214519A1 (es) 1979-06-29
MX5340E (es) 1983-06-27
IE44989L (en) 1977-10-13

Similar Documents

Publication Publication Date Title
EP0050563B1 (fr) Dérivés d'imidazo(1,2-a)pyridine, leur préparation et leur application en thérapeutique
US20190169113A1 (en) Ketamine Derivatives
JP2020040964A (ja) オキサチアジン様化合物を作製する方法
FI63404B (fi) Foerfarande foer framstaellning av antianoxiska 1,2,3,3a 4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de) (1,5)naftyridiner
EP0092458A2 (fr) Dérives d'imidazo(1,2-a)pyridine, leur préparation et leur application en thérapeutique
EP4114408A1 (fr) Dérivés de nicotinamide mononucléotide et de bis-nicotinamide dinucléotide pour le traitement de l'arythmie
JPS62212322A (ja) 医薬組成物および処置法
WO2023142729A1 (zh) 呋喃核糖基吡啶衍生物用于预防或治疗癫痫或惊厥的用途
CN115135646B (zh) 取代的多环化合物及其药物组合物和用途
EP0125636A1 (de) Pyridazinone, ihre Herstellung und Verwendung, Pyridazinone enthaltende Arzneimittel
DE2839279A1 (de) Derivate des 1,2,3,3a,8,8a-hexahydropyrrolo eckige klammer auf 2,3-b eckige klammer zu indols, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
CA2030217A1 (en) Pyridone-carboxylic acid derivatives useful as veterinary medicines
CA1162544A (en) Naphthyridine derivatives
CN113603689B (zh) 多环吡啶酮化合物及其药物组合物和用途
BRPI0903803B1 (pt) Composto, processo de preparação, composição farmacêutica e uso dos compostos
US5166348A (en) Bornyl and isobornyl esters of carboxylic acids of condensed tetrahydroquinoxalines
JPH0132826B2 (cs)
FR2475394A1 (fr) Compositions pharmaceutiques contenant l'hexahydro-1, 2, 3, 3a, 4, 5, 6h indolo (3, 2, 1 - d. e) (1, 5) naphtyridinone - 6
DE3900964A1 (de) Neue nukleoside, verfahren zu deren herstellung sowie arzneimittel, die diese verbindungen enthalten
EA047104B1 (ru) Соединения, пригодные для лечения инфекций вируса гриппа
JPH11130672A (ja) 脂質過酸化抑制剤
JPH01151580A (ja) ３−アシルアミノメチル−５，６，７，８−テトラヒドロイミダゾ［１，２−□Ｄａ］ピリジン誘導体
JP2821912B2 (ja) 動物用抗菌剤
TWI313602B (en) Gyrase inhibitors and uses thereof
DE2922084A1 (de) Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SYNTHELABO